e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Prognostic factors and subtyping of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prognostic significance of metastasis to aortopulmonary lymph nodes in completely resected left lung tumors
N. Citak, A. Sayar, M. Metin, S. Büyükkale, A. Kök, A. çelikten, O. Solak, S. Yurt, N. A. Fener, A. Gürses (Kars, Istanbul, Afyon, Turkey)
Source:
Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Session:
Prognostic factors and subtyping of lung cancer
Session type:
Thematic Poster Session
Number:
2912
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Citak, A. Sayar, M. Metin, S. Büyükkale, A. Kök, A. çelikten, O. Solak, S. Yurt, N. A. Fener, A. Gürses (Kars, Istanbul, Afyon, Turkey). The prognostic significance of metastasis to aortopulmonary lymph nodes in completely resected left lung tumors. Eur Respir J 2013; 42: Suppl. 57, 2912
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
The prevalence of metastasis to the aortopulmonary window lymph nodes (stations 5 and 6) in patients with left lung carcinoma: A retrospective analysis of 566 patients
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Mediastinal lymph nodes (MLN) vascular pattern utilitiy to predict progression in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients?
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Regulatory vs. cytotoxic cells in lymph nodes of lung cancer patients resected by TEMLA
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016
The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Lung cancer size and thoracic lymph nodes metastatic involvement: a correlation
Source: Eur Respir J 2004; 24: Suppl. 48, 671s
Year: 2004
Lung cancer size and thoracic lymph nodes metastatic involvement: A correlation
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
PET-CT predictors of mediastinal dissemination in lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014
PET and endobronchial ultrasound. SUV value of mediastinal lymph nodes suspicious for malignancy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Elastography strain ratio in the staging of mediastinal lymph nodes
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014
Significance of age, tumor location and histological subtype in lung cancer with brain metastasis
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Surgery of NSCLC with ipsilateral intrapulmonary metastases
Source: Eur Respir J 2001; 18: Suppl. 33, 375s
Year: 2001
Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016
Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Myeloid antigen presenting cells in lung adenocarcinoma lymph nodes assessed by endobronchial ultrasound
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016
EBUS-TBNA for nodal restaging and relapse in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Profile of non-neoplasic mediastinal lymph nodes (NNLN) during the study of lung cáncer (LC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Locoregional recurrence after pulmonary segmentectomy of non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept